Physician profile
Charles J Bogdan
NPI 1578586517
$1,950.41
in general payments reported to CMS, 2019-2025
18 companies · $461 in 2025
The $461 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.67 · 2020: $67.77 · 2021: $191 · 2022: $492 · 2023: $473 · 2024: $179 · 2025: $461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,113.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $739.92 | 2022-2025 | Inspire |
| Optinose US, INC. | $269.32 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $211.98 | 2021-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $144.84 | 2023-2025 | |
| Glaxosmithkline, LLC. | $140.46 | 2021-2025 | Nucala |
| Stryker Corporation | $117.71 | 2019-2025 | Scopis Ent, Neptune |
| Medtronic, INC. | $67.56 | 2022-2024 | Ligasure |
| Merck Sharp & Dohme LLC | $50.77 | 2021-2025 | Keytruda |
| Ethicon US, LLC | $34.02 | 2022 | |
| Alk-Abello, INC | $27.74 | 2019 | |
| Karl Storz Endoscopy-America | $24.38 | 2022 | |
| Genzyme Corporation | $23.69 | 2024 | |
| Ascendis Pharma Endocrinology INC | $23.14 | 2025 | Yorvipath |
| Cardinal Health 414 LLC | $19.47 | 2019 | |
| Kaleo, INC. | $18.24 | 2023 | Auvi-Q |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $13.17 | 2020 | |
| Conmed Corporation | $12.12 | 2022 | |
| Kls-Martin L.P. | $11.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Bogdan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.